Exploring the Mechanism of Astragalus propinquus Schischkin and Panax Notoginseng (A&P) Compounds in the Treatment of Renal Fibrosis and Chronic Kidney Disease Based on Integrated Network Analysis

Table 4

Molecular docking of A&P’s potential ingredients and core genes.

Drug	Molecule name	MolID	Affinity (kcal/mol)
			HSF1	RELA
Niuxi	Inophyllum E	MOL003847	−7.1	−7.3
Niuxi	Coptisine	MOL001458	−7.0	−7.4
Huangqi	Isorhamnetin	MOL000354	−6.8	−7.5
Niuxi	Baicalin	MOL002776	−6.8	−7.4
Sanqi	Ginsenoside rh2	MOL005344	−6.7	−6.7
Niuxi	Berberine	MOL001454	−6.6	−6.6
Huangqi	Hederagenin	MOL000296	−6.4	−7.1
Niuxi	Ecdysterone	MOL012542	−6.4	−6.7
Niuxi	Wogonin	MOL000173	−6.3	−6.5
Niuxi	Baicalein	MOL002714	−6.3	−6.6
Kunbu	Eckol	MOL010616	−6.3	−7.6
Huangqi	Jaranol	MOL000239	−6.2	−6.6
Niuxi	Epiberberine	MOL002897	−6.2	−6.2
Danggui	Stigmasterol	MOL000449	−6.2	−7.1
Huangqi	Quercetin	MOL000098	−6.1	−6.7
Niuxi	Poriferasta	MOL001006	−6.1	−6.6
Huangqi	Mairin	MOL000211	−6.0	−7.2
Kunbu	Fucosterol	MOL009622	−6.0	−6.9
Huangqi	7-O-Methylisomucronulatol	MOL000378	−5.9	−6.6
Huangqi	Formononetin	MOL000392	−5.9	−6.6
Huangqi	Calycosin	MOL000417	−5.9	−6.7
Niuxi	Beta-sitosterol	MOL000358	−5.9	−6.8
Kunbu	24-Methylenecholesterol	MOL010625	−5.9	−7.0
Sanqi	Diop	MOL002879	−5.9	−6.9
Kunbu	Saringosterol	MOL010615	−5.7	−6.9
Sanqi	DFV	MOL001792	−5.7	−6.0
Huangqi	Bifendate	MOL000387	−5.5	−6.0
Huangqi	FA	MOL000433	−5.4	−5.3
Huangqi	Kaempferol	MOL000422	−5.3	−6.8
Sanqi	Mandenol	MOL001494	−4.9	−4.5
Kunbu	1553-41-9	MOL010617	−4.0	−4.1